Showing results (341-350 of 374) with videos related to
Sort By:
Pageof 38
Iscience|May 1, 2023
A five-safes approach to a secure and scalable genomics data repositoryChih Chuan Shih, Jieqi Chen, Ai Shan Lee, et al.Nature Cardiovascular Research|May 13, 2025
Metabolome-wide association identifies ferredoxin-1 (FDX1) as a determinant of cholesterol metabolism and cardiovascular risk in Asian populationsNilanjana Sadhu, Rinkoo Dalan, Pritesh R Jain, et al.Gut|December 5, 2023
Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologiesJing Han Hong, Chern Han Yong, Hong Lee Heng, et al.Nature Communications|June 9, 2026
Genomic landscape of drug binding and pharmacogenetic variation across diverse populations using SNPdrug3DAshar J Malik, Dimitar Kenanov, Cheng-Shoong Chong, et al.Cancer Discovery|March 22, 2017
Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric AdenocarcinomaAditi Qamra, Manjie Xing, Nisha Padmanabhan, et al.Gut|August 26, 2021
Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibitionRaghav Sundar, Kie-Kyon Huang, Vikrant Kumar, et al.Clinical and Translational Medicine|June 15, 2024
Integrative genomic analyses of European intrahepatic cholangiocarcinoma: Novel ROS1 fusion gene and PBX1 as prognostic markerPatrick S Plum, Timo Hess, Denis Bertrand, et al.Science Translational Medicine|August 9, 2013
Genome-wide mutational signatures of aristolochic acid and its application as a screening toolSong Ling Poon, See-Tong Pang, John R McPherson, et al.Cancer Discovery|September 13, 2017
<i>VHL</i> Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell CarcinomaXiaosai Yao, Jing Tan, Kevin Junliang Lim, et al.Cell Reports|July 7, 2015
Recurrent Fusion Genes in Gastric Cancer: CLDN18-ARHGAP26 Induces Loss of Epithelial IntegrityFei Yao, Jaya P Kausalya, Yee Yen Sia, et al.Pageof 38